Oscar Health (OSCR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Voting matters and shareholder proposals
Election of eight director nominees to serve until the 2027 Annual Meeting, with all nominees recommended by the board.
Advisory vote on executive compensation (Say-on-Pay) is up for approval.
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026 is proposed.
Additional business may be addressed if properly brought before the meeting.
Board of directors and corporate governance
Eight director nominees are presented for election, including Mark T. Bertolini, William J. Gassen III, Joshua Kushner, Laura Lang, David Alexander Plouffe, Siddhartha Sankaran, Mario Schlosser, and Vanessa Ames Wittman.
Executive compensation and say-on-pay
Shareholders are asked to approve, on an advisory basis, the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Oscar Health
- AI, transparency, and financial incentives are reshaping consumer-driven healthcare strategies.OSCR
7th Annual Healthcare Symposium9 Jul 2026 - Q1 2025 revenue up 42%, net income up 55%, and membership exceeded 2 million.OSCR
Q1 20259 Jul 2026 - 2025 revenue up 28% with record membership; 2026 targets profitability and margin gains.OSCR
Q4 20258 Jul 2026 - Three-year plan targets 20% revenue CAGR, 5% margin, and ICHRA-driven growth, powered by technology.OSCR
Investor Day 20248 Jul 2026 - Strong 2026 performance, favorable trends, and AI-driven integrity shape a stable outlook.OSCR
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - Board transitions, robust growth, and all proposals approved; no Q&A from shareholders.OSCR
AGM 20264 Jun 2026 - Revenue and net income soared, membership surged, but regulatory risks persist.OSCR
Q1 20267 May 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and robust governance practices.OSCR
Proxy filing23 Apr 2026 - Strong 2026 enrollment and robust risk management drive optimism amid regulatory shifts.OSCR
47th Annual Raymond James Institutional Investor Conference2 Mar 2026